Eli Lilly (LLY)

• Market cap: $947B
• 1 day: 3.66%
• 5 days: 1.99%
• 1 month: -0.55%
• 3 months: 12.88%
• 6 months: 41.78%
• Year to date: -2.05%
• 1 year: 21.58%
• 5 years: 414.25%
• 10 years: 1,326.31%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 47,000